[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016

October 2016 | 103 pages | ID: G3E4CC9339AEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report

Mainly covers the following product types
  • Exenatied
  • Liraglutide
  • Lixisenatide
  • Albiglutide
  • Dulaglutide
The segment applications including
  • Hospital
  • Pharmacy
  • Other
Segment regions including (the separated region report can also be offered)
  • North America
  • Europe
  • China
  • Asia (Ex. China)
  • Other
The players list (Partly, Players you are interested in can also be added)
  • Novo Nordisk
  • AstraZeneca
  • Eli Lily
  • GSK
  • Sanofi
  • Bristol-Myers Squibb
  • Amylin
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 INDUSTRY OVERVIEW OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

1.1 Definition and Specifications of Glucagon like peptide-1 (GLP-1) agonists
  1.1.1 Definition of Glucagon like peptide-1 (GLP-1) agonists
  1.1.2 Specifications of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
  1.2.1 Exenatied
  1.2.2 Liraglutide
  1.2.3 Lixisenatide
  1.2.4 Albiglutide
  1.2.5 Dulaglutide
1.3 Applications of Glucagon like peptide-1 (GLP-1) agonists
  1.3.1 Hospital
  1.3.2 Pharmacy
  1.3.3 Other
1.4 Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists
1.5 Industry Overview and Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
  1.5.1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
  1.5.2 Global Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
1.6 Industry Policy Analysis of Glucagon like peptide-1 (GLP-1) agonists
1.7 Industry News Analysis of Glucagon like peptide-1 (GLP-1) agonists

2 MANUFACTURING COST STRUCTURE ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

2.1 Raw Material Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.2 Equipment Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.3 Labor Cost Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.4 Other Costs Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.5 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.6 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

3.1 Capacity and Commercial Production Date of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015

4 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Capacity and Growth Rate Analysis
  4.2.2 2015 Glucagon like peptide-1 (GLP-1) agonists Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Analysis
  4.3.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales Price
  4.4.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Gross Margin
  4.5.2 2015 Glucagon like peptide-1 (GLP-1) agonists Gross Margin Analysis (Company Segment)

5 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS REGIONAL MARKET ANALYSIS

5.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Analysis
  5.1.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Overview
  5.1.2 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
  5.1.4 North America 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.2 Europe Glucagon like peptide-1 (GLP-1) agonists Market Analysis
  5.2.1 Europe Glucagon like peptide-1 (GLP-1) agonists Market Overview
  5.2.2 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
  5.2.4 Europe 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.3 China Glucagon like peptide-1 (GLP-1) agonists Market Analysis
  5.3.1 China Glucagon like peptide-1 (GLP-1) agonists Market Overview
  5.3.2 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
  5.3.4 China 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.4 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Analysis
  5.4.1 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Overview
  5.4.2 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
  5.4.4 Asia (Ex. China) 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.5 Other Glucagon like peptide-1 (GLP-1) agonists Market Analysis
  5.5.1 Other Glucagon like peptide-1 (GLP-1) agonists Market Overview
  5.5.2 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
  5.5.4 Other 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis

6 GLOBAL 2011-2016E GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales by Type
6.2 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Interview Price Analysis
6.3 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Driving Factors Analysis
  6.3.1 Exenatied Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  6.3.2 Liraglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  6.3.3 Lixisenatide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  6.3.4 Albiglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  6.3.5 Dulaglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis

7 GLOBAL 2011-2016E GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Hospital Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  7.3.2 Pharmacy Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
  7.3.3 Other Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

8.1 Novo Nordisk
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.2 AstraZeneca
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.3 Eli Lily
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.4 GSK
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.5 Sanofi
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.7 Amylin
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 North America 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
  9.2.2 Europe 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
  9.2.3 China 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
  9.2.4 Asia (Ex. China) 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
  9.2.5 Other 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKETING MODEL ANALYSIS

10.1 Glucagon like peptide-1 (GLP-1) agonists Regional Marketing Model Analysis
10.2 Glucagon like peptide-1 (GLP-1) agonists International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Regions
10.4 Glucagon like peptide-1 (GLP-1) agonists Supply Chain Analysis

11 CONSUMERS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

12.1 New Project SWOT Analysis of Glucagon like peptide-1 (GLP-1) agonists
12.2 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists

13 CONCLUSION OF THE GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET PROFESSIONAL SURVEY REPORT 2016

More Publications

Need Help?

Ask a Question

Market Reports

All Categories